Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
Polycystic ovary syndrome is a complex metabolic and endocrine disorder featuring hyperglycemia, hyperandrogenism, disrupted ovulation, and inflammation. Hyperandrogenism induces inflammation through the NLRP3/NF-қB pathway, disturbing ovarian function and causing infertility. We aimed to study the impact of Carvacrol (CAR) on PCOS-associated complications using high fat-diet (HFD) and letrozole-administered rats. Using molecular docking and network pharmacology approaches, we identified NLRP3...
Published on: Fri, 20 Jun 2025 06:00:00 -0400
Authors: Arfah Siddiqua, Abdul Malik, Urooj Iqbal, Nabeela Tabassum Sial, Malik Hassan Mehmood, Muhammad Fayyaz Ur Rehman,
CONCLUSIONS: Administering COC pre-treatment for patients with PCOS undergoing ART does not provide substantial advantages in terms of clinical pregnancy, cumulative pregnancy, live birth rates, or the reduction of OHSS incidence. However, it is associated with an increased risk of miscarriage.
Published on: Fri, 20 Jun 2025 06:00:00 -0400
Authors: Yufei Liang, Qiquan Zhang, Zhaoxia Lou,
CONCLUSION: Seven percent of women in this sample showed probable PCOS based on clinical manifestations, with SES impacting quality of life, mental health, and sleep. Higher income reduced MD and MD+HIR risk, while infertility increased MD risk and severe depression was linked to MD+HIR.
Published on: Fri, 20 Jun 2025 06:00:00 -0400
Authors: Stephanie Mohammed, Venkatesan Sundaram, Brian N Cockburn, Shastri Motilal, Sasha Ottey, Ricardo Azziz,
CONCLUSION: The D* and f values of the ovarian stroma in PCOS patients are significantly increased, while the ADC and D values are significantly reduced. The combination of ADC and FN can improve the diagnostic efficacy for PCOS.
Published on: Fri, 20 Jun 2025 06:00:00 -0400
Authors: Keying Wang, Qian Song, Anrong Zeng, Ying Li, Jinwei Qiang,
CONCLUSION: These findings provide novel insights into the molecular mechanisms underlying AMH upregulation in PCOS. They highlight the CRTC1-CBP-AR transcriptional complex and HIPK2-mediated phosphorylation as critical regulatory nodes in PCOS pathogenesis.
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Yunmei Ke, Jinyan Zheng, Jinman Zhang, Dan Tang, Qin Yang, Han Zhao, Caifen Zhu, Yan Zhang,
CONCLUSION: This study reveals phenotype-specific metabolic signatures in PCOS and POR, identifying taurocholate, mycalemide, and N,N-dimethylglycine as potential follicular biomarkers. These findings contribute to a deeper understanding of the metabolic basis of infertility and highlight the potential of follicular fluid metabolomics for precision medicine in reproductive health.
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Metin Demirel, Mehtap Alim, Fatmanur Koktasoglu, Nil Atakul, Ebru Guner, Ayse Nur Işık Aydın, Sanem Naz Kafali, Yildız Atamer, Sahabettin Selek,
CONCLUSION: Increasing the FNPO cut-off of polycystic ovarian morphology excludes a significant number of women from the diagnosis of PCOS despite having comparable anthropometric and metabolic parameters. Robust data are required from different ethnic populations before the new cut-off for polycystic ovarian morphology is accepted or refuted, especially in populations with a higher prevalence of non-hyperandrogenic PCOS phenotypes.
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Reeta Mahey, Rohitha Cheluvaraju, Aarthi K Jayraj, Monika Rajput, Ashish Upadhyay, Ayushi Negi, Archana Kumari,
CONCLUSION: This first MR evidence demonstrates PA's differential causal effects on gynecologic disorders, particularly highlighting exercise modality-specific protection against ER^(+) BC, EC, and ES. Paradoxical PCOS associations warrant mechanistic investigation. Findings underscore PA as a modifiable preventive factor and advocate for subtype-tailored exercise guidelines in women's health.
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Mengyu Fu, Xiaoyue Zhu, Jie Chen, Jiewen Guan, Hongmei Ding, Qinqin Gao, Songbing Qin,
Extracellular vesicles (EVs) facilitate intercellular communication and the conveyance of bioactive substances, including proteins, lipids, and nucleic acids. They play a significant role in various reproductive biological processes, including gametogenesis, fertilization, early embryo development, and implantation. Dysfunctional EV activity is associated with various reproductive diseases, such as polycystic ovary syndrome (PCOS), endometriosis, male infertility, and recurrent pregnancy loss...
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Jinguang Wang, Dan Wang, Yuemin Zhang, Pingping Sun, Lankai Yi, Ailing Han, Wenjie Zhao, Yuhua Zhang, Huagang Ma,
CONCLUSIONS: The incorporation of consistent estrous cycle monitoring and biomarker measurements is crucial for the advancement of FHA research. Future studies should comprehensively investigate hormonal changes and explore potential therapeutic targets for ovarian inflammation and androgen involvement.
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Da-Yeong Min, Song-Yi Kim, Ji-Yeun Park, Minseo Kang, Byoung-Soo Kim,
CONCLUSIONS: In this review, we have highlighted the extreme variability in what is known about the genetics of ODRI by compiling and categorizing genes identified in the literature as associated with ODRI and its associated subtypes. We have also provided a comprehensive list of ODRI genes specifically identified in humans. The findings from this review, specifically the list of ODRI genes, can be used for targeted gene panel development in assisted reproductive technology to improve clinical...
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Erin E DiPietro, Sara M Sarasua, Casey S Hopkins, Satishkumar Ranganathan Ganakammal, Luigi Boccuto, Joshua Hurwitz,
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting approximately 10% of middle-aged women worldwide. It is characterized by hirsutism, anovulation, and polycystic ovaries. Various factors, including environmental toxins, inflammation, oxidative stress, and insulin resistance, contribute to the progression of this condition. PCOS is also associated with metabolic disturbances, such as abnormal hormone and neurotransmitter metabolism, leading to obesity, hyperandrogenemia,...
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Dongning Wu, Yue Zhang, Congying Wu, Bo An, Xin Wang, Jinxia Ni, Min Chen,
CONCLUSIONS: Although further efforts are needed to engage patients and providers in the process of developing specific measures, this framework provides a starting point for PCO research on BHCC.
Published on: Thu, 19 Jun 2025 06:00:00 -0400
Authors: Ashlyn Burns, Emily Meanwell, Justin Blackburn, Zachary Adams, Leslie Hulvershorn, Bernice Pescosolido,
CONCLUSION: These findings suggest that plasma OXM levels may not reflect body composition or insulin resistance in women with PCOS.
Published on: Wed, 18 Jun 2025 06:00:00 -0400
Authors: Rachel C Damasceno, Flávia R Oliveira, Ana Lúcia Cândido, Karina B Gomes, Mariana F Bizzi, Rosana C Azevedo, Fábio V Comim, Fernando M Reis, Ana Luiza Lunardi Rocha,
CONCLUSIONS: This study showed a significant correlation between metabolic markers, including BMI, FLI, VAI, HOMA-IR, and HRQOL in PCOS patients. BMI was the most meaningful predictor for HRQOL. BMI, despite being controversial and prone to errors, may be more indicative of HRQOL than specific metabolic markers.
Published on: Wed, 18 Jun 2025 06:00:00 -0400
Authors: Konstantin Hofmann, Susanne Singer, Susanne Theis, Annette Hasenburg, Roxana Schwab, Christine Skala,